Abstract
Butyrylcholinesterase (BuChE) is expressed in brain structures involved in cognition, but the effect of selective BuChE inhibitors on human cognitive function is unknown. We report a patient whose cognitive function deteriorated following a reduction and improved following reinstitution of ethopropazine, a selective BuChE inhibitor. We suggest that, because neurons expressing BuChE may be involved in cognition, there is merit to further evaluation of selective BuChE inhibitors in treating cognitive dysfunction.
| Original language | English |
|---|---|
| Pages (from-to) | 461-464 |
| Number of pages | 4 |
| Journal | International Psychogeriatrics |
| Volume | 13 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 2001 |
ASJC Scopus Subject Areas
- Clinical Psychology
- Gerontology
- Geriatrics and Gerontology
- Psychiatry and Mental health
PubMed: MeSH publication types
- Case Reports
- Journal Article
- Research Support, Non-U.S. Gov't
